Praxis Biologics Inc initial common stock offering 1750000 share 15.50 dlrs share. The company proceeds offering fund product research development include clinical testing. It money cover acquisition construction equipment cost work capital. The offering manage Shearson Lehman Bros Inc Merrill Lynch Capital Markets company said. Reuter 